10x Genomics, Inc. (TXG)
USD 7.64
(-4.86%)
USD 7.64
(-4.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -265.32 Million USD | -20.2% |
| 2022 | -167.94 Million USD | -217.4% |
| 2021 | -52.91 Million USD | 37.99% |
| 2020 | -85.32 Million USD | -193.5% |
| 2019 | -29.07 Million USD | 73.75% |
| 2018 | -110.76 Million USD | -502.8% |
| 2017 | -18.37 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -41.48 Million USD | 0.6% |
| 2024 Q2 | -41.73 Million USD | 29.73% |
| 2024 Q1 | -59.39 Million USD | -66.8% |
| 2023 Q3 | -94.79 Million USD | -49.62% |
| 2023 Q1 | -51.98 Million USD | -125.1% |
| 2023 Q4 | -35.61 Million USD | 62.43% |
| 2023 Q2 | -63.35 Million USD | -21.87% |
| 2023 FY | -201.86 Million USD | -20.2% |
| 2022 Q1 | -41.73 Million USD | -163.64% |
| 2022 FY | -167.94 Million USD | -217.4% |
| 2022 Q4 | -23.09 Million USD | 42.25% |
| 2022 Q3 | -39.99 Million USD | 36.63% |
| 2022 Q2 | -63.11 Million USD | -51.23% |
| 2021 Q2 | -10.32 Million USD | -1.1% |
| 2021 Q1 | -10.21 Million USD | 97.51% |
| 2021 Q4 | -15.83 Million USD | 0.31% |
| 2021 Q3 | -15.87 Million USD | -53.75% |
| 2021 FY | -52.91 Million USD | 37.99% |
| 2020 Q3 | -65.25 Million USD | -65.54% |
| 2020 Q4 | -409.58 Million USD | -527.66% |
| 2020 Q1 | -19.88 Million USD | -146.09% |
| 2020 FY | -85.32 Million USD | -193.5% |
| 2020 Q2 | -39.42 Million USD | -98.25% |
| 2019 Q2 | -10.36 Million USD | -241.42% |
| 2019 FY | -29.07 Million USD | 73.75% |
| 2019 Q4 | -8.08 Million USD | 11.17% |
| 2019 Q3 | -9.09 Million USD | 12.22% |
| 2019 Q1 | -3.03 Million USD | 95.95% |
| 2018 Q2 | -5.45 Million USD | 25.65% |
| 2018 Q4 | -74.96 Million USD | -402.01% |
| 2018 Q3 | -14.93 Million USD | -174.0% |
| 2018 Q1 | -7.33 Million USD | 0.0% |
| 2018 FY | -110.76 Million USD | -502.8% |
| 2017 FY | -18.37 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Accolade, Inc. | -114.45 Million USD | -131.824% |
| Aclarion, Inc. | -4.87 Million USD | -5341.551% |
| Aclarion, Inc. | -4.87 Million USD | -5341.551% |
| Augmedix, Inc. | -18.77 Million USD | -1312.903% |
| HeartBeam, Inc. | -15.31 Million USD | -1632.591% |
| HeartBeam, Inc. | -15.31 Million USD | -1632.591% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.36 Million USD | -4843.229% |
| Bullfrog AI Holdings, Inc. Warrants | -5.36 Million USD | -4843.229% |
| BrightSpring Health Services, Inc. Common Stock | 147.18 Million USD | 280.275% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 147.18 Million USD | 280.275% |
| CareCloud, Inc. | -47.11 Million USD | -463.152% |
| CareCloud, Inc. | -47.11 Million USD | -463.152% |
| CareCloud, Inc. | -47.11 Million USD | -463.152% |
| Certara, Inc. | -40.77 Million USD | -550.731% |
| CareMax, Inc. | -656.15 Million USD | 59.563% |
| CareMax, Inc. | -656.15 Million USD | 59.563% |
| Definitive Healthcare Corp. | -329.8 Million USD | 19.549% |
| EUDA Health Holdings Limited | -3.96 Million USD | -6598.444% |
| EUDA Health Holdings Limited | -3.96 Million USD | -6598.444% |
| Forian Inc. | -5.59 Million USD | -4642.242% |
| GoodRx Holdings, Inc. | -27 Million USD | -882.445% |
| GE HealthCare Technologies Inc. | 2.43 Billion USD | 110.896% |
| Health Catalyst, Inc. | -126.89 Million USD | -109.09% |
| Healthcare Triangle, Inc. | -11.34 Million USD | -2238.112% |
| HealthEquity, Inc. | 128.13 Million USD | 307.072% |
| HealthStream, Inc. | 16.01 Million USD | 1756.339% |
| iCoreConnect Inc. | -10.27 Million USD | -2481.875% |
| Inovalon Holdings, Inc. | 71.71 Million USD | 470.003% |
| MSP Recovery, Inc. | -559.87 Million USD | 52.609% |
| Mangoceuticals, Inc. | -9.21 Million USD | -2778.101% |
| National Research Corporation | 40.04 Million USD | 762.577% |
| Nutex Health, Inc. | -31.77 Million USD | -735.057% |
| Omnicell, Inc. | -34.86 Million USD | -660.953% |
| OneMedNet Corporation | -8.37 Million USD | -3068.391% |
| OptimizeRx Corporation | -26.4 Million USD | -904.969% |
| Ontrak, Inc. | -20.67 Million USD | -1183.333% |
| Ontrak, Inc. | -20.67 Million USD | -1183.333% |
| Progyny, Inc. | 62.18 Million USD | 526.684% |
| Premier, Inc. | 157.08 Million USD | 268.906% |
| Privia Health Group, Inc. | 20.64 Million USD | 1384.948% |
| R1 RCM Inc. | 147.9 Million USD | 279.398% |
| Renalytix Plc | -29.6 Million USD | -796.14% |
| Schrödinger, Inc. | -177.44 Million USD | -49.525% |
| Sharecare, Inc. | -96.47 Million USD | -175.024% |
| Sharecare, Inc. | -96.47 Million USD | -175.024% |
| SHL Telemedicine Ltd. | -9 Million USD | -2846.136% |
| Simulations Plus, Inc. | 6.13 Million USD | 4427.663% |
| SOPHiA GENETICS SA | -74.82 Million USD | -254.595% |
| Spok Holdings, Inc. | 21.22 Million USD | 1349.901% |
| Streamline Health Solutions, Inc. | -19.64 Million USD | -1250.481% |
| TruBridge, Inc. | -42.6 Million USD | -522.78% |
| Minerva Surgical, Inc. | -30.89 Million USD | -758.698% |
| GeneDx Holdings Corp. | -163.66 Million USD | -62.12% |
| GeneDx Holdings Corp. | -163.66 Million USD | -62.12% |
| SCWorx Corp. | -1.45 Million USD | -18190.201% |
| Zhongchao Inc. | -13.28 Million USD | -1897.388% |